Beam Therapeutics Inc
BEAM
Market Cap$2.04B
Close$
$-24.21
240.3% downside
Current Fair Value
240.3% downsideOvervalued by 240.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.04 Billion |
|---|---|
| Enterprise Value | $2.02 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.58 |
| Beta | 2.02 |
| Outstanding Shares | 82,824,151 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.45 |
|---|---|
| PEG | -737.16 |
| Price to Sales | 4.31 |
| Price to Book Ratio | 2.16 |
| Enterprise Value to Revenue | 5.79 |
| Enterprise Value to EBIT | -10.76 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Insider Trades
ESG Score
No data